跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VOSEVI 400MG/100MG/100MG F.C.TABLET - SFDA Drug Approval Details
Approvals
/
SFDA
/
VOSEVI 400MG/100MG/100MG F.C.TABLET
Authorized
NCE
VOSEVI 400MG/100MG/100MG F.C.TABLET
Unknown
🇸🇦 Saudi Food and Drug Authority
Approval Date
N/A
Approval ID
9c5dd7a5906cab50
Company
Unknown
Type
NCE
Approval Details
Approval Id
9c5dd7a5906cab50
Drug Approval Sfda Name
VOSEVI 400MG/100MG/100MG F.C.TABLET
Trade Name
VOSEVI 400MG/100MG/100MG F.C.TABLET
Generic Name
SOFOSBUVIR,VELPATASVIR,VOXILAPREVIR
Register Number
0402256812
Register Year
2019
Drug Type
NCE
Route Of Administration
Oral use
Package Type
Bottle
Package Size
28
Legal Status
Prescription
Authorization Status
Valid
Marketing Status
Marketed
Product Control
Uncontrolled
Storage Conditions
store below 30°c
Shelf Life
48 Months
Distribution Site
Pharmacy
Description Code
21000006272-600-100000073665
Price
35531.35
Active Ingredients
Authorized
Quick Info
Agency
SFDA
Country
🇸🇦
Approval ID
9c5dd7a5906cab50
Type
NCE
Back to SFDA Approvals